Showing results (1-10 of 40) with videos related to
Sort By:
Pageof 4
Current Opinion in Molecular Therapeutics|October 27, 2005
Viral vectors as therapeutic agents for glioblastomaManish Aghi, Samuel RabkinCurrent Opinion in Endocrinology, Diabetes, and Obesity|June 4, 2009
Recent advances in the treatment of acromegalyManish Aghi, Lewis S BlevinsMolecular Therapy : the Journal of the American Society of Gene Therapy|September 3, 2005
Contribution of bone marrow-derived cells to blood vessels in ischemic tissues and tumorsManish Aghi, E Antonio ChioccaOncogene|November 22, 2005
Oncolytic viral therapies - the clinical experienceManish Aghi, Robert L MartuzaProgress in Neurological Surgery|October 13, 2006
Benign adult brain tumors: an evidence-based medicine reviewManish Aghi, Fred G Barker IiJournal of the National Cancer Institute|January 5, 2006
Effect of chemotherapy-induced DNA repair on oncolytic herpes simplex viral replicationManish Aghi, Samuel Rabkin, Robert L MartuzaCancer Journal (Sudbury, Mass.)|September 4, 2003
Viral therapy for glioblastomaE Antonio Chiocca, Manish Aghi, Giulia FulciJournal of Neuro-Oncology|September 1, 2005
Breast adenocarcinoma metastatic to epidural cervical spine meningioma: case report and review of the literatureManish Aghi, Tim-Rasmus Kiehl, Jonathan L BrismanCancer Research|January 20, 2007
Angiogenic response caused by oncolytic herpes simplex virus-induced reduced thrombospondin expression can be prevented by specific viral mutations or by administering a thrombospondin-derived peptideManish Aghi, Samuel D Rabkin, Robert L MartuzaPageof 4